In early November, middle-market private equity firm Gryphon Investors signed a deal to acquire Revision Skincare. CEO Maria Carell talked to Happi about this deal and what it means across Revision Skincare's major franchises like Intellishade, DEJ and Nectifirm as well as its fast-growng contract manufacturing operation, Goodier Cosmetics.
 
We also discussed dermfluencers, TikTok and what’s to come in physician-dispensed skin care as we move into 2022. 

About Revision & Goodier Cosmetics
For more than two decades, Revision Skincare has provided dermatologists, plastic surgeons and medical spas with clinically proven, high-performing skincare products. Using only premium quality ingredients, the Revision Skincare collection was formulated to provide targeted solutions for enhancing skin's appearance and reducing signs of aging. Based in Irving, TX, Revision Skincare is sold in more than 10 countries.
 
Since 1922, Irving, TX-based Goodier Cosmetics has been a trusted developer and manufacturer in cosmetic and OTC topical skincare solutions. Differentiated by an industry renowned Innovation Center of Excellence, Goodier, along with its team of R&D chemists, engineers and regulatory experts, remains at the forefront of market trends, new technologies, ingredients and advancements in formulation science.
 
When the deal closes, Revision Goodier's management team will continue to be led by Carell. As part of the transaction, a number of Gryphon Executive Advisors will join Gryphon Operating Partner Mike Ferry, Gryphon Deal Partner Matt Farron, and Gryphon Principal Eddie Douglas on the board of directors.